246 SAMHSA-listed treatment centers in Connecticut. Free, confidential help available 24/7.
Browse 246 verified drug and alcohol treatment facilities in Connecticut. Each listing is sourced from federal databases and verified for accuracy. Use the information below to compare programs, verify insurance acceptance, and find the right facility for your needs.
Need help choosing? Call for free, confidential guidance from a treatment specialist.
Drug-overdose mortality in Connecticut reached 39.6 per 100k in the most recent CDC dataset, which is above the US baseline of 32.6. Treatment options on this page range from short-stay medical detox to multi-month residential to flexible outpatient care, all from federally-credentialed providers.
Listings are sourced from the federal SAMHSA treatment locator and updated quarterly against state licensing-board records. No pay-for-placement.
Discharge from a treatment program is the beginning, not the end, of recovery. The data is clear: people who engage in structured aftercare for 12+ months post-treatment have significantly better sobriety outcomes than those who stop at discharge.
Continuing outpatient therapy is the bridge from intensive treatment to long-term sobriety. Most insurance plans cover at least 6 months of weekly sessions.
30 days to 12+ months. Drug-free environment, peer accountability, employment expectations. Vet NARR certification.
The mutual-support landscape in Connecticut includes 12-step (AA/NA), cognitive (SMART Recovery), Buddhist (Refuge), and secular (LifeRing) options. Online meetings extend access.
MAT is a chronic-disease management strategy, not a short-term bridge. Connecticut patients on long-term MAT show materially lower relapse and overdose rates.
CPRS (Certified Peer Recovery Specialists) offer practical navigation help in Connecticut. Most services are free via state Medicaid or grant funding.
Narcan (naloxone) is the overdose-reversal medication. Available without prescription at Connecticut pharmacies and from many harm-reduction organizations. Train your inner circle.
The first 90 days post-discharge are highest-risk. Daily community contact, scheduled therapy/coaching, MAT continuity, written relapse-response plan.
Whether you choose a non-profit IOP in your hometown or a private residential program elsewhere in Connecticut, hours-per-day, group-therapy density, and medical-management cadence follow industry-standard patterns. The card grid below outlines the standard modalities.
Patients learn to map triggers, cravings, and use into a chain that can be interrupted at multiple points. Skills-based rather than insight-based.
Motivational Interviewing engages the person's own reasons to change rather than imposing them. Most effective in early-treatment ambivalence.
MAT is not a substitute therapy; it is treatment. The medication reduces craving and use; counseling addresses the psychological and social drivers.
For patients whose substance use is in the service of regulating overwhelming emotion, DBT's skill-based approach often resonates more than insight-oriented therapies.
About half of people entering addiction treatment also meet criteria for a trauma-related diagnosis. Specific therapies (EMDR, CPT, Seeking Safety) address both.
Peer-based mutual-support groups are the longest-running and most accessible aftercare resource in Connecticut. Daily meetings available in most urban and many rural areas.
Under the federal Mental Health Parity and Addiction Equity Act, most insurance plans in Connecticut must cover substance-use treatment at parity with physical-health benefits.
Aetna · Anthem · Blue Cross Blue Shield · Cigna · Humana · Kaiser Permanente · UnitedHealthcare · Medicare · HUSKY Health · Tricare (military) · VA Community Care
In Connecticut, Medicaid is administered as HUSKY Health. State-licensed facilities are typically required to accept it for substance-use treatment. Verify eligibility at medicaid.gov.
The research is unambiguous: addiction treatment outcomes improve when family members are engaged during the treatment episode and after discharge. Most Connecticut accredited programs now include structured family components.
Most Connecticut addiction treatment programs follow a similar five-step admission process. From first call to first day in treatment, expect 1–7 days depending on facility availability and insurance verification turnaround. Same-day admissions are possible for acute cases, especially at facilities providing medical detox in major Connecticut metro areas.
Without insurance, the cost of Connecticut treatment can seem prohibitive, but every uninsured-pathway in the state has been used by real people. The trick is matching pathway to your circumstance: income, veteran status, court involvement, religious openness.
| Level | Duration | OOP (insured) | Best fit |
|---|---|---|---|
| Medical detox | 3–7 days | $0–$3,000 | Severe alcohol/opioid withdrawal |
| Residential / Inpatient | 28–90 days | $0–$10,000 | Moderate-to-severe addiction, 24/7 structure needed |
| Partial Hospitalization (PHP) | 2–6 weeks | $0–$5,000 | 20+ hrs/wk structured care |
| Intensive Outpatient (IOP) | 8–12 weeks | $0–$2,500 | 9–19 hrs/wk, fits work/school |
| Standard Outpatient | 3–12+ months | $0–$1,500 | Aftercare or mild dependence |
If you are searching for treatment for yourself or a loved one in Connecticut, ask about specialty programming. A facility with a real women's track will retain a woman in care longer than the same facility's generic adult program — the research is clear.
Trauma-informed care, pregnancy-aware medical management, parenting groups.
Emotion-regulation focus, anger management, fatherhood support, identity processing.
School integration, family therapy required, lower-intensity longer-duration models.
Combat-trauma-aware programming, VA Community Care eligibility, military culture competence.
Identity-affirming therapy, anti-discrimination policies, family-of-choice integration.
Psychiatry on staff, integrated treatment of depression/anxiety/PTSD/bipolar alongside substance use.
Nursing/physician recovery monitoring, confidential reporting, return-to-practice protocols.
Late-onset alcohol-use disorder, polypharmacy concerns, age-appropriate group composition.
All statistics and policy claims sourced from federal-government and peer-reviewed agencies. Last verified May 2026.
Below is reference material for navigating addiction treatment in Connecticut — the levels of care that exist, the federal and state resources that support patients, the insurance landscape, and crisis support pathways. Each section is independent; start with whichever is most relevant to your current decision point.
Pregnant women in Connecticut with active substance use should not stop opioid use abruptly if dependent; withdrawal during pregnancy carries fetal risk including preterm labor and stillbirth. Evidence-based care for pregnant opioid-dependent patients is buprenorphine or methadone maintenance (NOT detox), continued through pregnancy and postpartum. Connecticut maternal-fetal medicine specialists, OB-GYNs trained in addiction medicine, and the SAMHSA-funded Center of Excellence for Pregnant and Postpartum Women with Opioid Use Disorder provide specialized care pathways.
Connecticut insurance considerations for addiction treatment center on three questions: (1) is the facility in-network with your plan, (2) what is the plan's out-of-pocket maximum and deductible status, and (3) are pre-authorization requirements met. In-network facilities have negotiated rates with your insurance and typically result in lower out-of-pocket costs. Out-of-network treatment is sometimes covered but at lower reimbursement rates and higher patient cost-sharing.
Treatment intensity in Connecticut ranges from weekly outpatient counseling at the lower end to 24-hour medically managed inpatient care at the higher end, with PHP and IOP occupying the middle. Movement between levels is bidirectional — patients can step up if outpatient proves insufficient, or step down as they stabilize. The goal is matching the level to current clinical need, then transitioning out of higher-cost settings as soon as safe.
Co-occurring medical conditions require coordinated management for Connecticut addiction patients. Common comorbidities: hepatitis C (curable with direct-acting antivirals); HIV (manageable with antiretroviral therapy); endocarditis (in IV drug users); chronic pain (requires non-opioid pain management strategy); diabetes; hypertension; chronic respiratory conditions. Integrated primary-care + addiction-treatment models address the whole patient; siloed care often results in poor outcomes for both conditions.
Connecticut addiction treatment operates within a federal regulatory framework set by SAMHSA, the FDA (medication approvals), the DEA (controlled-substance authority), and CMS (Medicare/Medicaid coverage rules). 42 CFR Part 2 governs the confidentiality of substance-use treatment records — stricter than HIPAA, requiring written patient consent for most disclosures. This means information about your treatment generally cannot be shared with employers, family members, or other providers without your written permission, with narrow exceptions for medical emergencies and child-abuse mandated reporting.
Medication-assisted treatment (MAT) is the evidence-based standard for opioid use disorder in Connecticut. Three medications carry FDA approval: methadone (full opioid agonist, dispensed only at federally certified opioid treatment programs); buprenorphine (partial agonist, prescribed in office-based settings by waivered providers); and naltrexone (opioid antagonist, available as monthly injection). Multiple RCTs and meta-analyses show MAT reduces overdose death by approximately 50% versus abstinence-based approaches. NIDA, SAMHSA, ASAM, and the AMA all endorse MAT as first-line.